Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al
oleh: Thomas Blankenstein, Lena Immisch, George Papafotiou, Oliver Popp, Philipp Mertins, Gerald Willimsky
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2023-03-01 |
Deskripsi
No description available for this item.